170 related articles for article (PubMed ID: 12894876)
21. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
22. [Preparation and biological activities of monoclonal antibody-streptonigrin immunoconjugates].
Liu YP; Wu JB
Yao Xue Xue Bao; 1992; 27(7):498-502. PubMed ID: 1442081
[TBL] [Abstract][Full Text] [Related]
23. Site-specific conjugation of bifunctional chelator BAT to mouse IgG1 Fab' fragment.
Li J; Wang XH; Wang XM; Chen ZL
Acta Pharmacol Sin; 2006 Feb; 27(2):237-41. PubMed ID: 16412275
[TBL] [Abstract][Full Text] [Related]
24. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.
Wilbur DS; Chyan MK; Hamlin DK; Nguyen H; Vessella RL
Bioconjug Chem; 2011 Jun; 22(6):1089-102. PubMed ID: 21513347
[TBL] [Abstract][Full Text] [Related]
25. [Cytotoxicity to hepatoma BEL-7402 cells of an antitumor monoclonal antibody-streptonigrin conjugate].
Liu Y; Wu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Jun; 15(3):212-6. PubMed ID: 8222008
[TBL] [Abstract][Full Text] [Related]
26. Preparation and biological evaluation of polymerizable antibody Fab' fragment targeted polymeric drug delivery system.
Lu ZR; Shiah JG; Kopecková P; Kopecek J
J Control Release; 2001 Jul; 74(1-3):263-8. PubMed ID: 11489505
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Cellular Targeting by Fab' vs Full-Length Antibodies in Antibody-Nanoparticle Conjugates (ANCs) Using CD4 T-cells.
Singh K; Canakci M; Kanjilal P; Williams N; Shanthalingam S; Osborne BA; Thayumanavan S
Bioconjug Chem; 2022 Mar; 33(3):486-495. PubMed ID: 35139308
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic effect of pingyangmycin on cultured KB cells.
Tai KW; Chang YC; Chou LS; Chou MY
Oral Oncol; 1998 May; 34(3):219-23. PubMed ID: 9692057
[TBL] [Abstract][Full Text] [Related]
29. Calcitonin gene-related peptide as an endogenous vasodilator: immunoblockade studies in vivo with an anti-calcitonin gene-related peptide monoclonal antibody and its Fab' fragment.
Tan KK; Brown MJ; Hargreaves RJ; Shepheard SL; Cook DA; Hill RG
Clin Sci (Lond); 1995 Dec; 89(6):565-73. PubMed ID: 8549074
[TBL] [Abstract][Full Text] [Related]
30. [Anticancer spectrum of pingyangmycin in vitro].
Li XT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):182-6. PubMed ID: 1706647
[TBL] [Abstract][Full Text] [Related]
31. Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes.
Uyama I; Kumai K; Yasuda T; Tagawa T; Ishibiki K; Kitajima M; Tadakuma T
Jpn J Cancer Res; 1994 Apr; 85(4):434-40. PubMed ID: 8200855
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of anti-CD5 F(ab')2 and Fab' immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mice.
Kohn FR; Fishwild DM; Bernhard SL; Better M; Kung AH
Int J Immunopharmacol; 1993 Nov; 15(8):871-8. PubMed ID: 7504661
[TBL] [Abstract][Full Text] [Related]
33. [Antitumor effect of adriamycin conjugated with downsized anti-endoglin monclonal antibody].
Li L; Huang FY; Huang YH; Zhou SL; Guo JL; Zhao HG; Tan GH; Wang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):340-3. PubMed ID: 22812233
[TBL] [Abstract][Full Text] [Related]
34. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
Cheng WW; Allen TM
J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
[TBL] [Abstract][Full Text] [Related]
35. Dextran modification of a Fab'--beta-lactamase conjugate modulated by variable pretreatment of Fab' with amine-blocking reagents.
Mikolajczyk SD; Meyer DL; Fagnani R; Hagan MS; Law KL; Starling JJ
Bioconjug Chem; 1996; 7(1):150-8. PubMed ID: 8742004
[TBL] [Abstract][Full Text] [Related]
36. Preparation and evaluation of a CD13/APN-targeting and hydrolase-resistant conjugate that comprises pingyangmycin and NGR motif-integrated apoprotein.
Li B; Zheng YB; Li DD; Zhen YS
J Pharm Sci; 2014 Apr; 103(4):1204-13. PubMed ID: 24504597
[TBL] [Abstract][Full Text] [Related]
37. The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates.
Goldstein D; Nassar T; Lambert G; Kadouche J; Benita S
J Control Release; 2005 Nov; 108(2-3):418-32. PubMed ID: 16226821
[TBL] [Abstract][Full Text] [Related]
38. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
[TBL] [Abstract][Full Text] [Related]
39. Altered pharmacokinetic and tumour localization properties of Fab' fragments of a murine monoclonal anti-CEA antibody by covalent modification with low molecular weight dextran.
Fagnani R; Halpern S; Hagan M
Nucl Med Commun; 1995 May; 16(5):362-9. PubMed ID: 7544884
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
